-transparent.png){kind=logo}
Domperidone (R 33812) was injected i.v. for the prevention of nausea and vomiting in a total of 395 cytostatic treatment courses in 172 patients. The total dose ranged from 1 to 40 mg and was given in one or several doses. Even after the administration of severely emetic substances, vomiting and nausea were largely prevented in hospitalized patients, but the results were rather poor in ambulatory patients. In all of the cytostatic treatment schedules very favourable results were obtained.
Related Publications
J Nogarède, and
M T Closon, and
A Clarysse, and
J Longueville, and
M Derouaux, and
A Ferrant, and
A Drochmans
June 1986,
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology,
J Nogarède, and
M T Closon, and
A Clarysse, and
J Longueville, and
M Derouaux, and
A Ferrant, and
A Drochmans
September 1980,
Der Anaesthesist,
J Nogarède, and
M T Closon, and
A Clarysse, and
J Longueville, and
M Derouaux, and
A Ferrant, and
A Drochmans
January 1978,
Arzneimittel-Forschung,
J Nogarède, and
M T Closon, and
A Clarysse, and
J Longueville, and
M Derouaux, and
A Ferrant, and
A Drochmans
September 1983,
Irish journal of medical science,
J Nogarède, and
M T Closon, and
A Clarysse, and
J Longueville, and
M Derouaux, and
A Ferrant, and
A Drochmans
September 1987,
International journal of radiation oncology, biology, physics,
J Nogarède, and
M T Closon, and
A Clarysse, and
J Longueville, and
M Derouaux, and
A Ferrant, and
A Drochmans
November 1978,
Der Anaesthesist,
J Nogarède, and
M T Closon, and
A Clarysse, and
J Longueville, and
M Derouaux, and
A Ferrant, and
A Drochmans
January 2000,
Antibiotics and chemotherapy,
J Nogarède, and
M T Closon, and
A Clarysse, and
J Longueville, and
M Derouaux, and
A Ferrant, and
A Drochmans
January 2004,
Anales del sistema sanitario de Navarra,
J Nogarède, and
M T Closon, and
A Clarysse, and
J Longueville, and
M Derouaux, and
A Ferrant, and
A Drochmans
January 1997,
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
J Nogarède, and
M T Closon, and
A Clarysse, and
J Longueville, and
M Derouaux, and
A Ferrant, and
A Drochmans
January 1998,
Cancer practice,
